A Study of LY3473329 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular Events
Clinical trial NCT05563246 · COMPLETED
Trial details
- NCT number
- NCT05563246
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-24
- Primary completion
- 2024-03-14
- Enrollment
- 233
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.